Recombinant Human IGF2R Protein，His

IGF2R (Insulin-like Growth Factor 2 Receptor) is a key component in the regulation of growth and development, primarily functioning to modulate the bioavailability of Insulin-like Growth Factor 2 (IGF2) and other ligands. Research has shown that IGF2R plays a critical role in various physiological processes, including cellular growth, differentiation, and apoptosis, making it a significant focus in cancer biology, metabolic disorders, and developmental diseases. The receptor functions through endocytosis, regulating the signaling pathways that influence cell proliferation and survival. Additionally, mutations or altered expression of IGF2R have been implicated in a range of malignancies, where loss of function may contribute to unregulated cell growth. The production of recombinant IGF2R proteins offers a valuable tool for studying its structure-function relationships, ligand interactions, and potential therapeutic applications. By utilizing recombinant DNA technology, researchers can generate large quantities of pure IGF2R proteins, enabling detailed biochemical assays and the development of targeted therapies. Furthermore, understanding the relationship between IGF2R and other signaling networks holds promise for uncovering novel approaches to cancer treatment and management of metabolic syndromes. The expanding body of research surrounding IGF2R positions it as a promising candidate for further exploration in both basic and translational sciences, with the potential to influence future strategies for disease intervention and management.